Shah J P, Loree T R, Dharker D, Strong E W
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
Am J Surg. 1993 Oct;166(4):331-5. doi: 10.1016/s0002-9610(05)80326-5.
The extent of surgical resection for differentiated carcinoma of the thyroid gland confined to one lobe remains controversial. Although primary tumor size and extrathyroid extension are associated with a poor prognosis, the presence of multifocal lesions is not associated with an adverse prognosis. Therefore, the role of lobectomy versus total thyroidectomy must be studied in a prospective, randomized trial. Due to the need for long-term follow-up, such a trial has not yet been undertaken. As an alternative to such a trial, we have identified 146 patients from a consecutive series of 931 previously untreated patients undergoing surgical treatment at 1 institution between 1930 and 1980. For this study of matched-pair analysis, 73 patients, aged 45 years or older, were matched in each arm for significant prognostic factors. One group underwent lobectomy, and the other group underwent total thyroidectomy. The 20-year survival rate in the lobectomy group was 82% compared with 73% in the total thyroidectomy group (p = not significant). The patterns of failure in these two groups of patients were examined. A comparison of the patients who underwent lobectomy with an unmatched group of patients who underwent lobectomy showed similar survival rates. On the other hand, unmatched patients undergoing total thyroidectomy had a poorer survival rate than the matched group. This signifies a more aggressive nature of disease in the unmatched group of patients undergoing total thyroidectomy. We therefore conclude that low-risk patients undergoing lobectomy are likely to do as well as those undergoing total thyroidectomy and without the increased risk of the morbidity of total thyroidectomy.
对于局限于一侧叶的甲状腺分化癌,手术切除范围仍存在争议。尽管原发肿瘤大小和甲状腺外侵犯与预后不良相关,但多灶性病变的存在与不良预后无关。因此,必须通过前瞻性随机试验来研究叶切除术与全甲状腺切除术的作用。由于需要长期随访,这样的试验尚未开展。作为此类试验的替代方法,我们从1930年至1980年期间在一家机构接受手术治疗的931例未经治疗的连续患者系列中确定了146例患者。在这项配对分析研究中,每组73例年龄在45岁及以上的患者根据重要预后因素进行配对。一组接受叶切除术,另一组接受全甲状腺切除术。叶切除术组的20年生存率为82%,而全甲状腺切除术组为73%(p值无统计学意义)。对这两组患者的失败模式进行了检查。将接受叶切除术的患者与未配对的接受叶切除术的患者组进行比较,生存率相似。另一方面,未配对的接受全甲状腺切除术的患者的生存率低于配对组。这表明未配对的接受全甲状腺切除术的患者组中疾病的侵袭性更强。因此,我们得出结论,低风险患者接受叶切除术的效果可能与接受全甲状腺切除术的患者相同,且不会增加全甲状腺切除术后发病的风险。